LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

LLY

1,048.7

+1.77%↑

JNJ

202.99

+1.44%↑

ABBV

233.02

-0.35%↓

UNH

309.14

-1.49%↓

AZN

88.99

-0.51%↓

Search

West Pharmaceutical Services Inc

Closed

SectorHealthcare

258.09 -0.78

Overview

Share price change

24h

Current

Min

255.64

Max

259.98

Key metrics

By Trading Economics

Income

8.2M

140M

Sales

38M

804M

P/E

Sector Avg

38.933

106.172

EPS

1.96

Dividend yield

0.32

Profit margin

17.406

Employees

10,600

EBITDA

19M

217M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+34.37% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.32%

2.31%

Market Stats

By TradingEconomics

Market Cap

-889M

19B

Previous open

258.87

Previous close

258.09

News Sentiment

By Acuity

50%

50%

190 / 374 Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

West Pharmaceutical Services Inc Chart

Past performance is not a reliable indicator of future results.

Related News

19 Nov 2025, 23:36 UTC

Hot Stocks

Stocks to Watch: Nvidia, Kulicke & Soffa, Regeneron

19 Nov 2025, 22:13 UTC

Earnings
Acquisitions, Mergers, Takeovers

Palo Alto Networks to Buy Chronosphere for $3.35 Billion, Posts Higher 1Q Revenue -- Update

19 Nov 2025, 21:55 UTC

Major Market Movers

Amgen Lung Cancer Drug Gets Full Approval From FDA

19 Nov 2025, 21:43 UTC

Acquisitions, Mergers, Takeovers

Palo Alto Networks to Buy Chronosphere for $3.35 Billion

19 Nov 2025, 23:55 UTC

Market Talk

Gold Rises on Possible Investment Demand -- Market Talk

19 Nov 2025, 23:54 UTC

Market Talk

BHP Vicuna JV Offers Significant Copper Output, At a Cost -- Market Talk

19 Nov 2025, 23:47 UTC

Earnings

Lenovo Group 2Q EPS $2.52 >0992.HK

19 Nov 2025, 23:46 UTC

Earnings

Lenovo Group: Delivered Double-Digit Yr-on-Yr Rev Growth Across All Main Business Groups and Sales Geographies >0992.HK

19 Nov 2025, 23:45 UTC

Earnings

Lenovo Group 2Q Rev $20.5B >0992.HK

19 Nov 2025, 23:42 UTC

Market Talk

Nikkei May Rise After Nvidia's Strong Earnings Soothe Investors' Nerves -- Market Talk

19 Nov 2025, 23:42 UTC

Market Talk

Global Equities Roundup: Market Talk

19 Nov 2025, 23:41 UTC

Earnings

Lenovo Group 2Q Adj Net $512.0M Vs. $409.0M >0992.HK

19 Nov 2025, 23:41 UTC

Earnings

Lenovo Group 2Q Net $340.0M Vs. Net $359.0M >0992.HK

19 Nov 2025, 23:40 UTC

Earnings

Lenovo Group 2Q Rev $20.45B Vs. $17.85B >0992.HK

19 Nov 2025, 22:55 UTC

Earnings

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 4th Update

19 Nov 2025, 22:41 UTC

Earnings

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 3rd Update

19 Nov 2025, 22:30 UTC

Acquisitions, Mergers, Takeovers

CICC Seeks Trading Halt in Hong Kong, Shanghai Stock Exchange

19 Nov 2025, 22:30 UTC

Earnings

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 2nd Update

19 Nov 2025, 22:30 UTC

Acquisitions, Mergers, Takeovers

CICC Plans to Acquire Brokerage Firms via Share-Swap Agreement

19 Nov 2025, 22:27 UTC

Acquisitions, Mergers, Takeovers

China International Capital Plans to Acquire Brokerage Firms Cinda Securities, Dongxing Securities

19 Nov 2025, 22:08 UTC

Earnings

ZTO Express (Cayman) 3Q Rev $1.67B >ZTO

19 Nov 2025, 22:00 UTC

Earnings

Investors Cheer Blockbuster Nvidia Earnings -- WSJ

19 Nov 2025, 21:58 UTC

Earnings
Acquisitions, Mergers, Takeovers

Palo Alto Networks to Buy Chronosphere for $3.35B, Posts Higher 1Q Rev -- Update

19 Nov 2025, 21:52 UTC

Earnings

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- Update

19 Nov 2025, 21:50 UTC

Market Talk
Earnings

Tech, Media & Telecom Roundup: Market Talk

19 Nov 2025, 21:49 UTC

Market Talk
Earnings

Nvidia Quiets Investor Fears With Ballooning Demand -- Market Talk

19 Nov 2025, 21:38 UTC

Earnings

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- WSJ

19 Nov 2025, 21:28 UTC

Acquisitions, Mergers, Takeovers

Palo Alto Networks to Buy Chronosphere for $3.35B

19 Nov 2025, 21:27 UTC

Acquisitions, Mergers, Takeovers

Exact Sciences Stock Jumps on Reported Deal Interest from Abbott Laboratories -- Barrons.com

19 Nov 2025, 21:24 UTC

Earnings
Acquisitions, Mergers, Takeovers

Palo Alto Networks 1Q Next-Generation Security ARR $5.9 B >PANW

Peer Comparison

Price change

West Pharmaceutical Services Inc Forecast

Price Target

By TipRanks

34.37% upside

12 Months Forecast

Average 349.56 USD  34.37%

High 375 USD

Low 311 USD

Based on 11 Wall Street analysts offering 12 month price targets forWest Pharmaceutical Services Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

11 ratings

10

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

213.26 / 219.27Support & Resistance

Short Term

Strong Bullish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

190 / 374 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat